Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Thomas, Douglas D. / Turk, Boris / Wittinghofer, Alfred


IMPACT FACTOR 2018: 3.014
5-year IMPACT FACTOR: 3.162

CiteScore 2018: 3.09

SCImago Journal Rank (SJR) 2018: 1.482
Source Normalized Impact per Paper (SNIP) 2018: 0.820

Online
ISSN
1437-4315
See all formats and pricing
More options …
Volume 400, Issue 7

Issues

Regulation and related mechanism of GSN mRNA level by hnRNPK in lung adenocarcinoma cells

Xiao-hui Liu
  • Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Jie Ma
  • Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Jun-xia Feng
  • Department of Nephrology, Huadu District People’s Hospital of Guangzhou, Southern Medical University, Guangzhou 510800, China
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Yuan Feng
  • Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Yun-fang Zhang
  • Corresponding author
  • Department of Nephrology, Huadu District People’s Hospital of Guangzhou, Southern Medical University, Guangzhou 510800, China
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Lang-xia Liu
  • Corresponding author
  • Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2019-03-08 | DOI: https://doi.org/10.1515/hsz-2018-0417

Abstract

Gelsolin (GSN) is an actin filament-capping protein that plays a key role in cell migration. Here we show that heterogeneous nuclear ribonucleoprotein K (hnRNPK) regulates GSN expression level by binding to the 3′-untranslated region (3′UTR) of GSN mRNA in non-small cell lung cancers (NSCLC) H1299 cells which are highly metastatic and express high level of GSN. We found that hnRNPK overexpression increased the mRNA and protein level of GSN, whereas hnRNPK knockdown by siRNA decreased the mRNA and protein level of GSN in both H1299 and A549 cells, indicating a positive role of hnRNPK in the regulation of GSN expression. Furthermore, hnRNPK knockdown affected the migration ability of H1299 and A549 cells which could be rescued by ectopic expression of GSN in those cells. Conversely, GSN knockdown in hnRNPK-overexpressing cells could abort the stimulatory effect of hnRNPK on the cell migration. These results suggest that hnRNPK function in the regulation of cell migration is GSN-dependent. Taken together, these data unveiled a new mechanism of regulation of the GSN expression by hnRNPK and provides new clues for the discovery of new anti-metastatic therapy.

Keywords: cell migration; GSN; hnRNPK; NSCLC

References

  • Arcaro, A. (1998). The small GTP-binding protein rac promotes the dissociation of gelsolin from actin filaments in neutrophils. J. Biol. Chem. 273, 805–813.CrossrefPubMedGoogle Scholar

  • Azuma, T., Witke, W., Stossel, T.P., Hartwig, J.H., and Kwiatkowski, D.J. (1998). Gelsolin is a downstream effector of rac for fibroblast motility. EMBO J. 17, 1362–1370.PubMedCrossrefGoogle Scholar

  • Barboro, P., Repaci, E., Rubagotti, A., Salvi, S., Boccardo, S., Spina, B., Truini, M., Introini, C., Puppo, P., and Ferrari, N. (2009). Heterogeneous nuclear ribonucleoprotein K: altered pattern of expression associated with diagnosis and prognosis of prostate cancer. Br. J. Cancer 100, 1608–1616.CrossrefPubMedWeb of ScienceGoogle Scholar

  • Carpenter, B., Mckay, M., Dundas, S.R., Lawrie, L.C., Telfer, C., and Murray, G.I. (2006). Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer. Br. J. Cancer 95, 921–927.CrossrefPubMedGoogle Scholar

  • Cervero, P., Himmel, M., Kruger, M., and Linder, S. (2012). Proteomic analysis of podosome fractions from macrophages reveals similarities to spreading initiation centres. Eur. J. Cell Biol. 91, 908–922.CrossrefPubMedWeb of ScienceGoogle Scholar

  • Chellaiah, M.A., Kizer, N., Silva, M., Alvarez, U., Kwiatkowski, D.J., and Hruska, K.A. (2000). Gelsolin deficiency blocks podosome assembly and produces increased bone mass and strength. J. Cell Biol. 148, 665–678.PubMedCrossrefGoogle Scholar

  • Chen, L., Hsueh, C., Tsang, N., Liang, Y., Chang, K., Hao, S., Yu, J., and Chang, Y. (2008). Heterogeneous ribonucleoprotein K and thymidine phosphorylase are independent prognostic and therapeutic markers for nasopharyngeal carcinoma. Clin. Cancer Res. 14, 3807–3813.PubMedCrossrefWeb of ScienceGoogle Scholar

  • Cunningham, C.C., Stossel, T.P., and Kwiatkowski, D.J. (1991). Enhanced motility in NIH 3T3 fibroblasts that overexpress gelsolin. Science 251, 1233–1236.PubMedCrossrefGoogle Scholar

  • De Corte, V., Gettemans, J., and Vandekerckhove, J. (1997). Phosphatidylinositol 4,5-bisphosphate specifically stimulates PP60c-src catalyzed phosphorylation of gelsolin and related actin-binding proteins. FEBS Lett. 401, 191–196.CrossrefGoogle Scholar

  • Desantis, C., Lin, C.C., Mariotto, A.B., Siegel, R.L., Stein, K.D., Kramer, J.L., Alteri, R., Robbins, A.S., and Jemal, A. (2012). Cancer treatment and survivorship statistics, 2014. CA Cancer J. Clin. 66, 252–271.Web of ScienceGoogle Scholar

  • Dosakaakita, H., Hommura, F., Fujita, H., Kinoshita, I., Nishi, M., Morikawa, T., Katoh, H., Kawakami, Y., and Kuzumaki, N. (1998). Frequent loss of gelsolin expression in non-small cell lung cancers of heavy smokers. Cancer Res. 58, 322–327.PubMedGoogle Scholar

  • Fan, X., Xiong, H., Wei, J., Gao, X., Feng, Y., Liu, X., Zhang, G., He, Q., Xu, J., and Liu, L. (2016). Cytoplasmic hnRNPK interacts with GSK3β and is essential for the osteoclast differentiation. Sci. Rep. 5, 17732–17732.Web of ScienceCrossrefGoogle Scholar

  • Gao, R., Yu, Y., Inoue, A., Widodo, N., Kaul, S.C., and Wadhwa, R. (2013). Heterogeneous nuclear ribonucleoprotein K (hnRNP-K) promotes tumor metastasis by induction of genes involved in extracellular matrix, cell movement, and angiogenesis. J. Biol. Chem. 288, 15046–15056.CrossrefPubMedWeb of ScienceGoogle Scholar

  • Gao, X., Feng, J., He, Y., Xu, F., Fan, X., Huang, W., Xiong, H., Liu, Q., Liu, W., and Liu, X. (2016). hnRNPK inhibits GSK3β Ser9 phosphorylation, thereby stabilizing c-FLIP and contributes to TRAIL resistance in H1299 lung adenocarcinoma cells. Sci. Rep. 6, 22999.Web of ScienceCrossrefPubMedGoogle Scholar

  • Habeck, M. (1999). Gelsolin: a new marker for breast cancer? Mol. Med. Today 5, 503.CrossrefPubMedGoogle Scholar

  • Habelhah, H., Shah, K., Huang, L., Ostarecklederer, A., Burlingame, A.L., Shokat, K.M., Hentze, M.W., and Ronai, Z. (2001). ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation. Nat. Cell Biol. 3, 325–330.PubMedCrossrefGoogle Scholar

  • Han, N., Li, W., and Zhang, M. (2013). The function of the RNA-binding protein hnRNP in cancer metastasis. J. Cancer Res. Ther. 9, 129.Web of ScienceCrossrefGoogle Scholar

  • Huang, B., Deng, S., Loo, S.Y., Datta, A., Yap, Y.L., Yan, B., Ooi, C.H., Dinh, T.D., Zhuo, J., Tochhawng, L., et al. (2016). Gelsolin-mediated activation of PI3K/Akt pathway is crucial for hepatocyte growth factor-induced cell scattering in gastric carcinoma. Oncotarget 7, 25391–25407.PubMedWeb of ScienceGoogle Scholar

  • Klimektomczak, K., Wyrwicz, L.S., Jain, S., Bomsztyk, K., and Ostrowski, J. (2004). Characterization of hnRNP K protein-RNA interactions. J. Mol. Biol. 342, 1131–1141.CrossrefPubMedGoogle Scholar

  • Kwiatkowski, D.J. (1999). Functions of gelsolin: motility, signaling, apoptosis, cancer. Curr. Opin. Cell Biol. 11, 103–108.CrossrefPubMedGoogle Scholar

  • Li, G.H., Arora, P.D., Chen, Y., McCulloch, C.A., and Liu, P. (2012). Multifunctional roles of gelsolin in health and diseases. Med. Res. Rev. 32, 999–1025.Web of SciencePubMedCrossrefGoogle Scholar

  • Li, L.P., Lu, C., Chen, Z.P., Ge, F., Wang, T., Wang, W., Xiao, C., Yin, X.F., Liu, L., and He, J.X. (2011). Subcellular proteomics revealed the epithelial-mesenchymal transition phenotype in lung cancer. Proteomics 11, 429–439.CrossrefPubMedWeb of ScienceGoogle Scholar

  • Liepelt, A., Mossanen, J.C., Denecke, B., Heymann, F., De Santis, R., Tacke, F., Marx, G., Ostareck, D.H., and Ostarecklederer, A. (2014). Translation control of TAK1 mRNA by hnRNP K modulates LPS-induced macrophage activation. RNA 20, 899–911.Web of ScienceCrossrefPubMedGoogle Scholar

  • Linder, S., Higgs, H.N., Hufner, K., Schwarz, K., Pannicke, U., and Aepfelbacher, M. (2000). The polarization defect of Wiskott-Aldrich syndrome macrophages is linked to dislocalization of the Arp2/3 complex. J. Immunol. 165, 221–225.CrossrefPubMedGoogle Scholar

  • Matoulkova, E., Michalova, E., Vojtesek, B., and Hrstka, R. (2012). The role of the 3′ untranslated region in post-transcriptional regulation of protein expression in mammalian cells. RNA Biol. 9, 563–576.Web of ScienceCrossrefPubMedGoogle Scholar

  • Matta, A., Tripathi, S.C., Desouza, L.V., Grigull, J.o., Kaur, J., Chauhan, S.S., Srivastava, A., Thakar, A., Shukla, N.K., and Duggal, R. (2009). Heterogeneous ribonucleoprotein K is a marker of oral leukoplakia and correlates with poor prognosis of squamous cell carcinoma. Int. J. Cancer 125, 1398–1406.Web of ScienceCrossrefPubMedGoogle Scholar

  • Mukhopadhyay, N.K., Kim, J., Cinar, B., Hager, M.H., Vizio, D.D., Adam, R.M., Rubin, M.A., Raychaudhuri, P., De Benedetti, A., and Freeman, M.R. (2009). Heterogeneous nuclear ribonucleoprotein K is a novel regulator of androgen receptor translation. Cancer Res. 69, 2210–2218.Web of SciencePubMedCrossrefGoogle Scholar

  • Parkin, D.M., Bray, F., Ferlay, J., and Pisani, P. (2005). Global cancer statistics, 2002. CA Cancer J. Clin. 55, 74–108.CrossrefPubMedGoogle Scholar

  • Paziewska, A., Wyrwicz, L.S., Bujnicki, J.M., Bomsztyk, K., and Ostrowski, J. (2004). Cooperative binding of the hnRNP K three KH domains to mRNA targets. FEBS Lett. 577, 134–140.PubMedCrossrefGoogle Scholar

  • Sataranatarajan, K., Lee, M.J., Mariappan, M.M., and Feliers, D. (2008). PKCδ regulates the stimulation of vascular endothelial factor mRNA translation by angiotensin II through hnRNP K. Cell. Signal. 20, 969–977.CrossrefPubMedWeb of ScienceGoogle Scholar

  • Shanmugam, N., Reddy, M.A., and Natarajan, R. (2008). Distinct roles of heterogeneous nuclear ribonuclear protein K and microRNA-16 in cyclooxygenase-2 RNA stability induced by S100b, a ligand of the receptor for advanced glycation end products. J. Biol. Chem. 283, 36221–36233.PubMedCrossrefWeb of ScienceGoogle Scholar

  • Shieh, D., Godleski, J.J., Herndon, J.E., Azuma, T., Mercer, H., Sugarbaker, D.J., and Kwiatkowski, D.J. (1999). Cell motility as a prognostic factor in Stage I nonsmall cell lung carcinoma: the role of gelsolin expression. Cancer 85, 47–57.CrossrefGoogle Scholar

  • Tanaka, M., Mullauer, L., Ogiso, Y., Fujita, H., Moriya, S., Furuuchi, K., Harabayashi, T., Shinohara, N., Koyanagi, T., and Kuzumaki, N. (1995). Gelsolin: a candidate for suppressor of human bladder cancer. Cancer Res. 55, 3228–3232.PubMedGoogle Scholar

  • Tanaka, H., Shirkoohi, R., Nakagawa, K., Qiao, H., Fujita, H., Okada, F., Hamada, J., Kuzumaki, S., Takimoto, M., and Kuzumaki, N. (2006). siRNA gelsolin knockdown induces epithelial-mesenchymal transition with a cadherin switch in human mammary epithelial cells. Int. J. Cancer 118, 1680–1691.CrossrefPubMedGoogle Scholar

  • Taniuchi, K., Furihata, M., Naganuma, S., Dabanaka, K., Hanazaki, K., and Saibara, T. (2016). Podocalyxin-like protein, linked to poor prognosis of pancreatic cancers, promotes cell invasion by binding to gelsolin. Cancer Sci. 107, 1430–1442.PubMedCrossrefWeb of ScienceGoogle Scholar

  • Thisted, T., Lyakhov, D.L., and Liebhaber, S.A. (2001). Optimized RNA targets of two closely related triple KH domain proteins, heterogeneous nuclear ribonucleoprotein K and αCP-2KL, suggest distinct modes of RNA recognition. J. Biol. Chem. 276, 17484–17496.PubMedCrossrefGoogle Scholar

  • Wang, H., Chen, C., Yang, C., Tsai, I., Hou, Y., Chen, C., and Shan, Y.S. (2017). Tumor-associated macrophages promote epigenetic silencing of gelsolin through DNA methyltransferase 1 in gastric cancer cells. Cancer Immunol. Res. 5, 885–897.PubMedCrossrefWeb of ScienceGoogle Scholar

  • Yang, J., Tan, D., Asch, H.L., Swede, H., Bepler, G., Geradts, J., and Moysich, K.B. (2004). Prognostic significance of gelsolin expression level and variability in non-small cell lung cancer. Lung Cancer 46, 29–42.CrossrefPubMedGoogle Scholar

  • Yang, J., Ramnath, N., Moysich, K.B., Asch, H.L., Swede, H., Alrawi, S., Huberman, J.A., Geradts, J., Brooks, J.J., and Tan, D. (2006). Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer. BMC Cancer 6, 203–203.CrossrefPubMedGoogle Scholar

  • Zhang, J., Liu, X., Lin, Y., Li, Y., Pan, J., Zong, S., Li, Y., and Zhou, Y. (2016). HnRNP K contributes to drug resistance in acute myeloid leukemia through the regulation of autophagy. Exp. Hematol. 44, 850–856.PubMedCrossrefWeb of ScienceGoogle Scholar

  • Zhao, P., Dai, M., Chen, W., and Li, N. (2010). Cancer Trends in China. Jpn. J. Clin. Oncol. 40, 281–285.PubMedCrossrefGoogle Scholar

  • Zhou, C. (2014). Lung cancer molecular epidemiology in China: recent trends. Transl. Lung Cancer Res. 3, 270–279.PubMedGoogle Scholar

About the article

aXiao-hui Liu and Jie Ma: These authors contributed equally to this work.


Received: 2018-10-31

Accepted: 2019-02-11

Published Online: 2019-03-08

Published in Print: 2019-06-26


Funding Source: Guangdong Natural Science Foundation, Guangdong, China

Award identifier / Grant number: S2013030013315, 2016A030313083, and 2018A030313544

Funding Source: Science and Technology Program of Guangzhou, Guangdong, China

Award identifier / Grant number: 201607010175, 201707010263, and 201804010066

The authors would like to thank members of the Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes for providing discussion and support throughout the present study. The present study was supported by grants from the Guangdong Natural Science Foundation, Guangdong, China (Funder Id: 10.13039/501100003453, grant nos.: S2013030013315, 2016A030313083, and 2018A030313544) and the Science and Technology Program of Guangzhou, Guangdong, China (grant nos.: 201607010175, 201707010263, and 201804010066).


Citation Information: Biological Chemistry, Volume 400, Issue 7, Pages 951–963, ISSN (Online) 1437-4315, ISSN (Print) 1431-6730, DOI: https://doi.org/10.1515/hsz-2018-0417.

Export Citation

©2019 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Comments (0)

Please log in or register to comment.
Log in